Nkarta (NASDAQ:ANNX) Director Acquires $3,400,000.00 in Stock

Nkarta (NASDAQ:ANNX) Director Muneer A. Satter bought 200,000 shares of the business’s stock in a transaction on Tuesday, July 28th. The stock was bought at an average price of $17.00 per share, with a total value of $3,400,000.00.

Shares of NASDAQ ANNX opened at $18.54 on Friday. Nkarta has a 52 week low of $15.33 and a 52 week high of $19.00.

Nkarta Company Profile

Annexon, Inc, a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune and neurodegenerative diseases. It focuses on the treatment of body, brain, and eye disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated neurodegeneration.

See Also: What is the Shanghai Stock Exchange Composite Index?

Receive News & Ratings for Nkarta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nkarta and related companies with MarketBeat.com's FREE daily email newsletter.